Select your language close

Dr Christine Dahl

Consultant Oncologist


  • Neuro-Oncology
  • Paediatric brain tumours
  • MD 1997
  • PhD 1998-2002
  • Internship 2003-2004
  • Training in paediatrics 2004-2010
  • Haematology/Oncology 2010-2012, Denmark
  • Paediatric neonatology/Intensive Care 2012-2015, Denmark
  • Paediatric Haematology/Oncology 2015-2016, Denmark
  • Chief fellow Neuro Oncology 2016-2017, SickKids, Toronto
  • Paediatric Haematology/Oncology 2017-2018, Denmark
  • Paediatric Oncology, 2018-, GOSH, London

Late effects after treatment for childhood brain tumours 

News & Publications

Dahl C, Moxon-Emre I, Ramaswamy V, Bartels U, Tabori U, Huang A, Cushing SL, Papaioannou V, Larriere N, Mabbot DJ, Bouffet E, Hearing Loss and impairment of intellectual outcome following treatment for embryonal posterior fossa tumours in childhood. 2018 submitted for Holm M, Andersen HB, Hetland TE, Dahl C, Hoffmann HJ, Junker S, Schiotz PO. Seven week culture of functional human mast cells from buffy coat preparations. J Immunol Methods, 2008 Jul 32:336(2):213-21

Dahl C, Fuursted K, Schroeder H. A paediatric case of Candida Pericarditis and oesophageal stricture during treatment for ALL. Acta Oncol. 2007; 46 (6): 859-61

Dr Christine Dahl Details

Share Dr Christine Dahl profile with someone:

Browse A-Z